Biometric access control platform

Centralizing user database and devices management with MorphoManager

Biometric access control platform IDEMIA

For a wide variety of organizations, biometrics is an efficient means to identify their employees and visitors. IDEMIA’s portfolio of biometric terminals for access control and time & attendance can be managed seamlessly from a centralized platform: MorphoManager.

This application can administrate a maximum of 5,000 terminals and it can enroll fingerprint (contact or contactless acquisition), finger vein/print and facial recognition templates for up to 100,000 users, as well as encode contactless smartcards. User data can be protected with advanced encryption, providing compliance with the most stringent privacy regulations. MorphoManager offers a comprehensive range of activity reports, while transaction histories are made available for import into payroll systems.

MorphoManager can operate standalone or be interfaced with third party access control and time & attendance systems. Various pack options – bundling the application with an enrolment scanner – are available, depending on the installation size and the types of technology deployed.


Ask for a quote

  • Simplified management

    MorphoManager handles the full range of IDEMIA terminals – whatever the biometric modality – from a single point, optimizing their control and deployment via LAN, WAN or Wi-Fi.

  • Scalability

    From a handful to 100,000 users and up to 5,000 terminals, MorphoManager can be deployed on a single PC or in a client/server configuration.

  • Flexible integration

    MorphoManager by IDEMIA is already integrated with more than 25 leading access control platforms and can also be deployed as a standalone system.

Let's get in touch

Looking for additional information?
Our experts are available for you.

Contact us


Subscribe to our newsletter

Receive our key news and keep up with the trends in our markets by subscribing to our newsletter.

By clicking on the "Subscribe" button, you confirm that you agree to IDEMIA’s Terms of Use and Privacy Policy, and agree to the processing of your personal data and acknowledge your related rights, as described therein.

Your email address will be used exclusively by IDEMIA to send you newsletters related yo your selected topics of interest. In accordance with the law, you have rights of access, rectification and erasure of your personal data, as well as opposition of processing, which can be exercised by writing to